1[1]Steiner G, Stewart D, Hosking TD, et al. Baseline characteristic of the study population in the diabetes atherosclerosis intervention study (DAIS). Am J Cardiol, 1999,84:1004～1010.
2[2]Kelly DT. Cardiovascular medicine at the turn of the millennium. Eur Heart J Suppls, 2000, 2(suppl D), D68～69.
3[3]Herlitz J, Malmberg K, Karlson BW, et al. Mortality and morbidity during a five - year follow - up of diabetics with myocardial infarction. Acta Med Scand, 1988, 224:31.
4[4]Kannel WB. Diabetes and cardiovascular disease. JAMA,1979,241:2035～2038.
5[5]De Fronzo RA. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. Coron Artery Dis, 1992, 3:11～25.
6[6]Yokoyama I, Yonekura K, Ohtake T, et al. Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease. J Nucl Med, 2000,41:978～985.
7[7]Durante W, Sunahara FA, Amar KS. Effect of diabetes on metabolic coronary dilatation. Cardiovas Res, 1989, 23:40～45.
8[8]Zhao G, Zhang XP, Smith CJ, et al. Reduced coronary NO production in conscious dogs after the development of alloxaninduced diabetes. Am J Physiol, 1999, 277:H268～278.
9[9]Sebbag L, Forrat R, Canet E, et al. Effect of experimental non -insulin requiring diabetes on myocardial microcirculation during ischaemia in dogs. Eur J Clin Invest, 1994,24:686～690.
10[10]Nitenberg A, Valensi P, Sachs R, et al. Impairment of coronary vascular reserve and Ach - induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes, 1993,42:1017～1025.
